Vitamin D-Related Genes and Thyroid Cancer-A Systematic Review
Vitamin D-Related Genes and Thyroid Cancer-A Systematic Review
Maciejewski et al., 2022 | Int J Mol Sci | Meta Analysis
Citation
Maciejewski Adam, Lacka Katarzyna. Vitamin D-Related Genes and Thyroid Cancer-A Systematic Review. Int J Mol Sci. 2022-Nov-07;23(21). doi:10.3390/ijms232113661
Abstract
Vitamin D, formerly known for its role in calcium-phosphorus homeostasis, was shown to exert a broad influence on immunity and on differentiation and proliferation processes in the last few years. In the field of endocrinology, there is proof of the potential role of vitamin D and vitamin D-related genes in the pathogenesis of thyroid cancer-the most prevalent endocrine malignancy. Therefore, the study aimed to systematically review the publications on the association between vitamin D-related gene variants (polymorphisms, mutations, etc.) and thyroid cancer. PubMed, EMBASE, Scopus, and Web of Science electronic databases were searched for relevant studies. A total of ten studies were found that met the inclusion criteria. Six vitamin D-related genes were analyzed (VDR-vitamin D receptor, CYP2R1-cytochrome P450 family 2 subfamily R member 1, CYP24A1-cytochrome P450 family 24 subfamily A member 1, CYP27B1-cytochrome P450 family 27 subfamily B member 1, DHCR7-7-dehydrocholesterol reductase and CUBN-cubilin). Moreover, a meta-analysis was conducted to summarize the data from the studies on VDR polymorphisms (rs2228570/FokI, rs1544410/BsmI, rs7975232/ApaI and rs731236/TaqI). Some associations between thyroid cancer risk (VDR, CYP24A1, DHCR7) or the clinical course of the disease (VDR) and vitamin D-related gene polymorphisms were described in the literature. However, these results seem inconclusive and need validation. A meta-analysis of the five studies of common VDR polymorphisms did not confirm their association with increased susceptibility to differentiated thyroid cancer. Further efforts are necessary to improve our understanding of thyroid cancer pathogenesis and implement targeted therapies for refractory cases.
Key Findings
Further efforts are necessary to improve our understanding of thyroid cancer pathogenesis and implement targeted therapies for refractory cases.
Outcomes Measured
- Requires manual extraction
Population
| Field | Value |
|---|---|
| Population | See abstract |
| Sample Size | See abstract |
| Age Range | See abstract |
| Condition | See abstract |
MeSH Terms
- Humans
- Genetic Predisposition to Disease
- Polymorphism, Single Nucleotide
- Vitamin D
- Vitamin D3 24-Hydroxylase
- Risk Factors
- Receptors, Calcitriol
- Thyroid Neoplasms
- Genotype
Evidence Classification
- Level: Meta Analysis
- Publication Types: Systematic Review, Meta-Analysis, Journal Article
- Vertical: vitamin-d-cancer
Provenance
- PMID: 36362448
- DOI: 10.3390/ijms232113661
- PMCID: PMC9658610
- Verified: 2026-04-09 via PubMed E-utilities API
Source extracted via PubMed E-utilities API on 2026-04-09